Eagle Health Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-23,686	Closed	-$10.8M	–	33
2025 Q3	$10.8M	Sell	23,686 -22,400	-49%	-$9.12M	2.84%	14
2025 Q2	$15M	Sell	46,086 -19,570	-30%	-$5.42M	3.71%	12
2025 Q1	$17.7M	Sell	65,656 -10,600	-14%	-$2.72M	4.6%	10
2024 Q4	$17.9M	Hold	76,256	–	–	4.4%	12
2024 Q3	$21M	Hold	76,256	–	–	4.04%	12
2024 Q2	$18.5M	Buy	76,256 +27,900	+58%	+$4.4M	3.31%	14
2024 Q1	$7.23M	Sell	48,356 -88,400	-65%	-$14.7M	1.38%	22
2023 Q4	$26.2M	Hold	136,756	–	–	5.32%	9
2023 Q3	$24.2M	Hold	136,756	–	–	5.34%	9
2023 Q2	$26M	Hold	136,756	–	–	4.86%	9
2023 Q1	$27.4M	Sell	136,756 -18,960	-12%	-$3.99M	5.33%	8
2022 Q4	$37M	Sell	155,716 -6,000	-4%	-$1.28M	8.54%	2
2022 Q3	$32.4M	Buy	161,716 +12,336	+8%	+$2.35M	7.43%	3
2022 Q2	$21.8M	Buy	149,380 +18,136	+14%	+$2.57M	5.08%	8
2022 Q1	$21.4M	Buy	131,244 +17,542	+15%	+$2.67M	5.28%	8
2021 Q4	$19.3M	Buy	113,702 +23,600	+26%	+$4.39M	4.7%	9
2021 Q3	$17M	Sell	90,102 -18,077	-17%	-$3.39M	5.4%	7
2021 Q2	$18.3M	Hold	108,179	–	–	6.29%	5
2021 Q1	$15.3M	Buy	108,179 +22,386	+26%	+$3.37M	6.2%	8
2020 Q4	$11.2M	Buy	+85,793	New	+$11.5M	7.13%	6